Drug intelligence / Profile preview

ciproterone acetate + ethinylestradiol

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

Ciproterone acetate + ethinylestradiol is a fixed-dose combination oral medication containing two active ingredients: ciproterone acetate, a synthetic steroidal antiandrogen and progestogen, and ethinylestradiol, a synthetic estrogen. This combination is primarily used in women of reproductive age to treat conditions associated with androgen excess such as moderate to severe acne, seborrhea (oily skin), hirsutism (excessive hair growth), and symptoms of polycystic ovary syndrome (PCOS) when other treatments have failed. It also provides effective contraception during treatment for these conditions[1][4][6][7][8]. Mechanistically, ciproterone acetate acts by blocking androgen receptors and suppressing ovarian androgen production via negative feedback on the hypothalamic-pituitary-gonadal axis. Ethinylestradiol increases sex hormone-binding globulin (SHBG) levels, reducing free circulating androgens[5]. The combination regularizes menstrual cycles in PCOS patients. The product carries an increased risk of venous thromboembolism compared to some other contraceptives[7]. It should not be used solely for contraception or in women with contraindications to estrogen/progestogen therapy.

Brand names
Diane-35Diane35Diane 35Estelle-35Estelle35Estelle 35Estelle-35 EDEstelle35 EDEstelle 35 EDCuestra-35Cuestra35Cuestra 35KrimsonGinetteMY PillElestraFrewilCARpelaCysteliaEstranonFemigrace
Other names
cyproterone acetate and ethinyl estradiol
02

Targets

PR (Progesterone receptor)AR (Adrenergic receptors)ER (Estrogen receptor)

Beyond the preview

Go deeper on ciproterone acetate + ethinylestradiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ciproterone acetate + ethinylestradiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call